Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

AMGEVITA HCF 40 mg solution for injection in pre-filled syringe

Active Ingredient:
adalimumab
Company:  
Amgen Ltd See contact details
ATC code: 
L04AB04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Amgevita HCF Patient Reminder Card - Adults

This card has important safety information about AMGEVITA. To request a copy of the patient alert card please contact Amgen medical information on 01223 436441 or by email to [email protected].

{pdf_link}

Amgevita HCF Patient Reminder Card - Paediatrics

This card has important safety information about AMGEVITA. To request a copy of the patient alert card please contact Amgen medical information on 01223 436441 or by email to [email protected].

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Amgen Ltd
Company image
Address
216 Cambridge Science Park, Milton Road, Cambridge, CB4 0WA, UK
Telephone
+44 (0)1223 420 305
Fax
+44 (0)1223 426 314
Medical Information Direct Line
+44 (0)1223 436 441
Medical Information e-mail
[email protected]
Medical Information Fax
+44 (0)1223 426 314